Authors
Lingyan Fang, Chenhuan Lai, Yanan Chen, Caoxing Huang, Qi Hua, Qiang Yong
Published in
Applied biochemistry and biotechnology. Jul 21, 2026. Epub Jul 21, 2026.
Abstract
This study evaluated the impact of two xylo-oligosaccharide (XOS) samples on gut microbiota from sub-healthy individuals with smoking-associated gut dysbiosis via in vitro fermentation. Sample S1 contained partially retained soluble small-molecular lignin (over 2%) with molecular weights of Mn = 685 Da and Mw = 1264 Da, whereas S2 was a highly purified XOS preparation with negligible soluble lignin content. Compared to S2, the S1 treatment resulted in a higher relative abundance of beneficial genera such as Bifidobacterium(6.6% vs. 5.4%) and Megamonas(46.3% vs. 32.3%), and a lower abundance of potentially harmful bacteria including Fusobacterium(6.7% vs. 21.6%) and Escherichia-Shigella(1.6% vs. 8.7%). Moreover, fermentation with S1 resulted in increased production of short-chain fatty acids, particularly acetic acid, indicating improved microbial metabolic activity and gut health potential. Additionally, S1 achieved 63.5% DPPH scavenging at 2 × 10- 3 g/mL and showed distinctly superior antioxidant performance relative to S2 with negligible radical-scavenging ability, which may contribute to protecting gut microbiota from oxidative stress and supporting overall intestinal barrier function. These results suggest that retention of soluble lignin in XOS enhances its prebiotic efficacy by modulating gut microbiota composition, metabolic function, and antioxidant capacity, supporting its promising application in functional food development and human health promotion.
PMID:
42479389
Bibliographic data and abstract were imported from PubMed on 21 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0